Cite

HARVARD Citation

    Faqar-Uz-Zaman, S. et al. (2018). BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis. Cancer letters. pp. 131-142. [Online]. 
  
Back to record